No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US OptionsDetailed Quotes
MNKD250117C3500
- 2.60
- -0.91-25.93%
15min DelayClose Jan 14 16:00 ET
2.60High2.60Low
2.60Open3.51Pre Close1 Volume4.15K Open Interest3.50Strike Price260.00Turnover0.00%IV1.16%PremiumJan 17, 2025Expiry Date2.53Intrinsic Value100Multiplier2DDays to Expiry0.07Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma2.41Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Intraday
- 5D
- Daily
News
MannKind Announces Upcoming Retirement of Lauren Sabella
Press Release: MannKind Expands Executive Leadership Team
Here's Why MannKind Corporation (NASDAQ:MNKD) Is Among the Best Diabetes Stocks to Buy Under $10
MannKind Expands Executive Leadership Team
MannKind Shares Rise After Wells Fargo Begins Coverage
Leerink Partners Maintains MannKind(MNKD.US) With Buy Rating, Announces Target Price $9